Licensing Red/ET recombination

Gene Bridges GmbH owns the exclusive rights to Red/ET recombination and issues licenses for the use of this technology to commercial users. Licensing arrangements for Red/ET recombination are provided as world-wide, non-exclusive sub-licenses.



Licensing KEIO collection

The KEIO collection was developed with the use of Gene Bridges' Red/ET Recombination technology and is covered by patent rights.

If you are a commercial organization and wish to acquire the KEIO collection from NAIST, you will need to complete the following sub-license from Gene Bridges. Upon completion of the license, NAIST will be able to complete you order. Gene Bridges will inform NAIST of the completion of the license agreement.

KEIO_Commercial License.pdf

Non-commercial organizations such as universities must complete a non-commercial sub-license and provide this to NAIST during ordering. Please do not send the sub-license to Gene Bridges.


KEIO_Non-commercial.pdf

For more information please contact licenses@genebridges.com

To the top

Please choose your country. If the country is missing, continue.

Shanghai QF Biosciences
Shanghai QF Biosciences
NeuProCell
Biotech Desk
NeuProCell
Biotech Desk
BioTag
BioTag
Funakoshi
Funakoshi
Mbiotech
Mbiotech
iDNA
iDNA
iDNA
iDNA
iDNA
iDNA
iDNA
iDNA
Gendiscovery
Gendiscovery
BioCat
BioCat
BioCat
BioCat
BioCat
BioCat
Biovalley
Biovalley
Quimigen
Quimigen
Brunschwig Chemie
Brunschwig Chemie
Cambio
Cambio
Cambio
Cambio
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Nanodiagnostika
Immuno Diagnostic
Nanodiagnostika
Nanodiagnostika
Nanodiagnostika
Nanodiagnostika
Nanodiagnostika
AS ONE INTERNATIONAL, INC.
AS ONE INTERNATIONAL, INC.
Valquim
Valquim